Back
Arcturus Therapeutics Holdings Stock Predictions
Sponsored
ARCT
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
38
ARCT
Arcturus Therapeutics Holdings
Last Price:
18.25
Seasonality Move:
9.45%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Arcturus Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 27.6% based on the past 11 years of stock performance.
- Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?
The current Arcturus Therapeutics Holdings [ARCT] share price is $18.33. The Score for ARCT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 27.6% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
38
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
- Arcturus Therapeutics Holdings has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
17.26
Prediction Charts
Market Cap:
495.68M
Price in USD:
18.33
Volume:
777.9K
Beta:
2.54
Technical Analysis
SMA50:
20.68
SMA100:
21.75
SMA200:
27.62
52-Wk Change:
-0.49%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?
Yes, Arcturus Therapeutics Holdings is a publicly traded company. -
What is the Arcturus Therapeutics Holdings stock quote today?
The Arcturus Therapeutics Holdings stock price is 18.33 USD today. -
How to buy Arcturus Therapeutics Holdings stock online?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-18 | 20.78 | 21.15 | 21.17 | 20.47 |
Oct-21 | 20.98 | 20.88 | 21.20 | 20.44 |
Oct-22 | 20.69 | 19.79 | 20.71 | 19.67 |
Oct-23 | 19.71 | 20.00 | 20.36 | 19.35 |
Oct-24 | 20.10 | 19.00 | 20.10 | 18.67 |
Oct-25 | 19.04 | 18.95 | 19.57 | 18.62 |
Oct-28 | 19.09 | 19.57 | 20.13 | 18.78 |
Oct-29 | 19.26 | 19.12 | 19.36 | 18.91 |
Oct-30 | 18.88 | 18.42 | 19.01 | 18.14 |
Oct-31 | 18.31 | 17.73 | 18.35 | 17.66 |
Nov-1 | 18.09 | 18.00 | 18.36 | 17.50 |
Nov-4 | 18.16 | 17.82 | 18.30 | 17.53 |
Nov-5 | 17.71 | 18.35 | 18.40 | 17.26 |
Nov-6 | 19.14 | 18.33 | 19.30 | 17.73 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.